NCT00331786View on ClinicalTrials.gov

Nitric Oxide-Releasing Acetylsalicyclic Acid in Preventing Colorectal Cancer in Patients at High Risk of Colorectal Cancer

PHASE1CompletedINTERVENTIONAL

Enrollment

240

Participants

Timeline

Start Date

July 31, 2006

Conditions

Colorectal Cancer

Interventions

DRUG

nitric oxide-releasing acetylsalicylic acid derivative

OTHER

laboratory biomarker analysis

PROCEDURE

biopsy

Trial Locations (1)

11794-8174

Stony Brook University Cancer Center, Stony Brook

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Stony Brook University

OTHER

NCT00331786 - Nitric Oxide-Releasing Acetylsalicyclic Acid in Preventing Colorectal Cancer in Patients at High Risk of Colorectal Cancer | Biotech Hunter | Biotech Hunter